Flexion Therapeutics Inc (NASDAQ:FLXN) announced financial results for the year-ended December 31, 2013.At December 31, 2013, Flexion had cash, cash equivalents and marketable securities totaling $16.4 million compared to $29.4 million at December 31, 2012. In February 2014, the successful completion of the company’s initial public offering of common stock raised gross proceeds of approximately $75 million.Flexion Therapeutics Inc (NASDAQ:FLXN) shares after opening at $15.25 moved to $16.56 on last trade day and at the end of the day closed at $16.15.Company price to cash ratio as 12.00. Flexion Therapeutics Inc (NASDAQ:FLXN) showed a negative weekly performance of -6.38%.
After surpassing its previously announced revenue objective in reporting of year 2013 financial results, GTT Communications Inc (NYSEMKT:GTT) promised to be more focused on expanding its technology offering. The company said that its cloud networking technology had greater opportunities in the world market. However, it needed to pair up or at least, following in the footsteps of industry giants.GTT Communications Inc (NYSEMKT:GTT) shares advanced 5.11% in last trading session and ended the day on $11.10. GTT return on equity ratio is recorded as -146.20% and its return on assets is -13.10%. GTT Communications Inc (NYSEMKT:GTT) yearly performance is 258.06%.
Visit ChyronHego at NAB Show 2014, Booth SL1110 – ChyronHego (NASDAQ: CHYR)’s NAB Show 2014 press conference at 9 a.m. on Sunday, April 6, at the Las Vegas Convention Center, room N242. The company highlighted its latest product launches, customer wins and corporate development initiatives. Chyronhego Corp (NASDAQ:CHYR) shares moved up 7.26% in last trading session and was closed at $2.66, while trading in range of $2.43-$2.79. Chyronhego Corp (NASDAQ:CHYR) year to date performance is 25.47%.
Equities research analysts at CRT Capital started coverage on shares of Gentiva Health Services (NASDAQ:GTIV) in a research note issued to investors on Tuesday,TheFlyOnTheWall.com reports. The firm set a “buy” rating and a $10.50 price target on the stock. CRT Capital’s price objective would indicate a potential upside of 19.73% from the company’s current price. The analysts noted that the move was a valuation call. Gentiva Health Services, Inc. (NASDAQ:GTIV) weekly performance is -7.46%. On last trading day company shares ended up $7.94. Gentiva Health Services, Inc. (NASDAQ:GTIV) distance from 50-day simple moving average is -17.85%. Analysts mean target price for the company is $10.14.